Pancreatic tumors. Additional benefit of adjuvant and neoadjuvant therapy?;Pankreaskarzinom. Optimierung durch adjuvante und neoadjuvante Therapie?

Zentralblatt fur Chirurgie

Volumn 124, Issue 5, 1999, Pages 401-407

  Maurer, C A ^b   Zgraggen, K ^b   Buchler M W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b NONE

Author keywords

Adjuvant; Chemotherapy; Immunotherapy; Neoplasms; Pancreas; Radiation; Regional

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; HUMAN; PANCREAS CANCER; PREOPERATIVE RADIOTHERAPY; SURGICAL MORTALITY;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; NEOADJUVANT THERAPY; PANCREATIC NEOPLASMS; PROGNOSIS; RADIOTHERAPY, ADJUVANT;

EID: 0032995855     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Andrén-Sandberg A, Bäckman PL, Andersson R (1997) Results of adjuvant therapy in resected pancreatic cancer. Int J Pancreatol 21: 31-38
2. Andrén-Sandberg A, Ihse I (1996) Pattern of recurrence after pancreaticoduodenectomy for exocrine pancreatic cancer - correlation to survival. In: Hanyo H (Hrsg): Pancreaticoduodenectomy. Tokyo: Springer
3. Bakkevold KE, Arnesio B, Dahl O, Kambestad B (1993) Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater - results of a controlled, prospective, randomised multicenter study. Eur J Cancer 5: 698-703
4. Baumel H, Huguier M, Manderscheid JC, Fabre JM, Houry S, Fagot H (1994) Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg 81: 102-107
5. Bosset JF, Pavy JJ, Gillet M, Mantion G, Pelisser E, Schraub S (1992) Conventional external irradiation alone as adjuvant treatment in resectable pancreatic cancer: result of a prospective study. Radiother Oncol 24: 191-194
6. Bramhall SR, Neoptolemos JP (1997) Adjuvant chemotherapy in pancreatic cancer. Int J Pancreatol 21: 59-63
7. Brennan MF, Kinsella TJ, Casper ES (1993) Cancer of the pancreas In: DeVita VT Jr, Hellmann S, Rosenberg SA (Hrsg): Cancer: principles and practice of oncology, 4. Aufl. S 849-882. Philadelphia Lippincott
8. Büchler MW, Friess H, Schultheiss KH, Gebhardt C, Kübel R, Muhrer KH, Winkelmann M, Wagener T, Klapdor R, Kaul M, Müller G, Schulz G, Beger HG (1991) A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer. Cancer 68: 1507-1512
9. Carter WB, Carter DL, Cohn HE (1993) Cause and current management of reoperative hyperparathyroidism. Am Surg 59: 120-124
10. Doppman JL (1986) Reoperative parathyroid surgery: localization procedures. Progress in Surgery 18: 117-132
11. Douglass HO, Stablein DM (1990) Ten-year follow-up of first generation surgical adjuvant studies of the Gastrointestinal Tumor Study Group. In: Salmon SE (Hrsg) Adjuvant therapy of cancer IV, S 405-415. Philadelphia: Saunders
12. Dudley NE (1971) Methylene blue for rapid identification of theparathyroids. BMJ 3: 680-681
13. Edis AJ, Sheedy PF, Bearhs OH, Van Heerden JA (1978) Results of reoperation for hyperparathyreoidism, with evaluation of preoperative localisation studies. Surgery 84: 384-393
14. Farnebo LO, Trigonis C, Forsgren L, et al (1984) Surgery for primary hyperparathyroidism. Acta Chirurgica Scand 520: 11-16
15. Foo ML, Gunderson LL, Nagorney DM, et al (1993) Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation + 5 fluorouracil. Int J Radiat Oncol Biol Phys 26: 483-489
16. Friess H, Gassmann M, Büchler MW (1997) Adjuvant therapy of pancreatic cancer using monoclonal antibodies and immune response modifies. Int J Pancreatol 21: 43-52
17. Gastrointestinal Tumor Study Group (1987) Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59: 2006-2010
18. Geer RJ, Brennan MF (1993) Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165:68-72
19. Griffin JF, Smalley SR, Jewell W, et al (1990) Patterns of failure after curative resection of pancreatic carcinoma. Cancer 66: 56-61
20. Hoffmann JP, Weese JL, Solin LJ, et al (1995) Preoperative chemoradiation for patients with resectable pancreatic adenocarcinoma: An Eastern Cooperative Oncology Group (ECOG) phase II study. Proc Am Soc Clin Oncol 14: 201
21. Ihse I, Andersson H, Andrén-Sandberg A (1996) Total pancreatectomy for cancer of the pancreas: is itappropriate? World J Surg 20: 288-294
22. Irvin GL, Dembrow VD, Prudhomme DL (1991) Operative monitoring of parathyroid gland hyperfunction. Am J Surg 162: 299-302
23. Ishikawa D, Ohhigashi H, Sasaki Y, Kabuto T, Fukuda I, Furukawa H, Imoaka S, Iwanaga T (1988) Practical usefulness of lymphatic and connective tissue in the clearance for the carcinoma of the pancreas head. Ann Surg 208: 215-220
24. Ishikawa O, Ohigashi H, Sasaki Y, Furukawa H, Kabuto T, Kameyama M, Nakamori S, Hiratsuka M, Imaoka S (1994) Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg 168: 361-365
25. Jessup JM, Steele G Jr, Mayer RJ, Posner M, Busse P. Cady B, Stone M, Jenkins R, Osteen R (1993) Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 128: 559-564
26. Johnstone PA, Sindelar WF (1993) Lymph node involvement and pancreatic resection: correlation with prognosis and local disease control in a clinical trial. Pancreas 8: 535-539
27. Kaiser MH, Ellenberg SS (1985) Pancreatic cancer: adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120: 899-903
28. Kamthan AG, Morris JC, Dalton J, Mandeli JP, Chesser MR, Leben D. Cooperman A, Bruckner HW (1997) Combined modality therapy for stage II and stage III pancreatic carcinoma. J Clin Oncol 15: 2920-2927
29. Kayahara M, Nabakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I (1993) An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determinde by autopsy and diagnostic imaging. Cancer 72: 2118-2123
30. Klinkenbijl JHG, Sahmoud T, van Pel R, Couvreur ML, Veenhof CHN, Arnaud JP, Hennipman A, Wils J, Jeekel J (1997) Radiotherapy and 5-FU after curative resection for the cancer of the pancreas and peri-ampullary region: A phase III trial of the EORTC GITCCG: Abstract-book, ECO-Meeting in Hamburg 1997
31. Kopelson G (1983) Curative surgery for adenocarcinoma of the pancreas/ampulla of Vater: the role of adjuvant pre or postoperative radiation therapy. Int J Radiation Oncology Biol Phys 9: 911-915
32. Lieberman MD, Kilbrun H, Lindsey M, Brennan MF (1995) Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 222: 638-645
33. Link K-H, Gansauge F, Pillasch J, Beger HG (1997) Multinodal therapies in ductal pancreatic cnacer. Int J Pancreatol 21: 71-83
34. Link KH, Gansauge F, Pillasch J, Rilinger N, Büchler M, Beger HG (1994) Regional treatment of advanced nonresectable and of resected pancreatic cancer via celiac axis infusion. First results of a single institution study. Dig Surg 11: 414-419
35. Link KH, Gansauge F, Rilinger N, Beger HG (1997) Celiac artery adjuvant chemotherapy. Int J Pancreatol 21: 65-69
36. Livingston EH, Welton ML, Reber HA (1991) Surgical treatment of pancreatic cancer. The United States experience. Int J Pancreatol 9: 153-157
37. Manabe T, Oshio G, Baba N, Miyashita T, Asano N, Tamura K, Yamaki K, Nonaka A, Tobe T (1989) Radical pancreatectomy for ductal carcinoma of the head of the pancreas. Cancer 64: 1132-1137
38. Moertel CG, Childs DS Jr, Reitemeyer RJ, et al (1969) Combined 5-fluorouracil and super voltage radiation therapy of locally unresectable gastro-intestinal cancer. Cancer 2: 865-867
39. Neoptolemos JP, Russell CG, Bramhall S, Theis B (1997) Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. Br J Surg 84: 1370-1376
40. Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer Statistics, 1997. Ca Cancer J Clin 47: 5-27
41. Pedrazzoli S, Di Carlo V, Dionigi R, Michelassi F, Mosca F, Pederoli P (1997) Does extended lymphadenectomy improve survival in the surgical treatment of pancreatic cancer? Results of a prospective trial. Digestion 58 (Suppl 2): 19 (Abstract)
42. Pilepich MV, Miller HH (1980) Preoperative irradiation in carcinoma of the pancreas. Cancer 46: 1945-1949
43. Roldan GE, Gunderson LL, Nagonrey DM, Martin JK, Ilstrup DM, Holbrook MA, Kvols LK, McIlrath DC (1988) External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer. Cancer 61: 1110-1116
44. Russel CF, Edis AJ (1982) Surgery for primary hyperparathyroidism: experience with 500 consecutive cases and evaluation of the role of surgery in the asymptomatic patient. Br J Surg 69: 244-247
45. Satava RM, Beahrs OH, Scholz DA (1975) Successful rate of surgical exploration for hyperparathyroidism. Arch Surg 110: 625-628
46. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S (1997) Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21: 195-200
47. Spitz FR, Abbruzzese JL, Lee JE, Pisters PWT, Lowy AM, Fenoglio CJ, Cleary KR, Janjan NA, Goswitz MS, Rich TA, Evans DB (1997) Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15: 928-937
48. Splinter TA, Obertop H, Kok TC, Jeekel J (1989) Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. A non-randomized pilot study. J Cancer Res Clin Oncol 115: 200-202
49. Staley CA, Lee JE, Cleary KR, et al (1996) Preoperative chemoradiaton, pancreaticoduodenectomie, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 171: 118-125
50. Trede M, Schwall G, Saeger H-D (1990) Survival after pancreatoduodenectomy. 188 resections without an operative mortality. Ann Surg 211: 447-458
51. Van Heerden JA, Grant CS (1991) Surgical treatment of primary hyperparathyreoidism: an institutional perspective. World J Surg 15: 688-692
52. Weese JL, Nussbaum ML, Paul AR, Engstrom PF, Solin LJ, Kowalyshyn MJ, Hoffman JP (1990) Increased resectability of locally advanced pancreatic and periampullary carcinoma with neoadjuvant chemoradiotherapy. Int J Pancreatol 7: 177-185
53. Whittington R, Bryer MP, Haller DG, et al (1991) Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 21: 1137-1143
54. Willett CG, Lewandrowski K, Warshaw AL, Efrid J, Compton CC (1993) Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 217:144-148
55. Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Zahurak ML, Dooley WC, Coleman J, Sauter PK, Pitt HA, Lillemoe KD, Cameron JL (1997) Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective single-institution experience. Ann Surg 225: 621-633
56. Zerbi A, Fossati V, Parolini D, Carlucci M, Balzano G, Bordogna G, Staudacher C, Di Carlo V (1994) Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer 73: 2930-2935